Конструирование рекомбинантных аденовирусов птиц CELO, экспрессирующих протективные антигены вирусов болезни Марека и гриппа птиц
Диссертация
Практическая значимость. Ген гемагглютинина вируса гриппа птиц штамма H5N2 и гены гликопротеинов gB, gE и gl вируса болезни Марека штамма RB1B, клонированные в плазмидном векторе pGEM-T-Easy, коллекция рекомбинантных аденовирусов: CELO-HA, CELO-gB, CELO-gE и CELO-gl, — хранятся в музее лаборатории молекулярной биотехнологии ГУ НИИ эпидемиологии и микробиологии им. Н. Ф. Гамалеи РАМН (ГУ НИИ ЭМ… Читать ещё >
Список литературы
- Гловер Д. /Новое в клонировании ДНК. Методы. //Москва. Мир, 1989. С. 209−236.
- Грин М. /Трансформация и онкогенез, ДНК-содержащие вирусы. // «Вирусология» под ред. Филдс, «Мир», 1989.
- Григорьев В.П., Хилько С. Н., Тихоненко Т. И. /Условия стабильности четвертичной структуры и антигенная активность гексона аденовирусов // Биохимия, 1985.- т.50.-С. 258−263.
- Коровин Р. Н, Рождественский И. К. /Аденовирусные инфекции птиц //Ленинград. 1990.
- Кругляк В.А., Акопиан Т. А., Народицкий Б. С., Карташова И. М., Шевлягин В. Я., Тихоненко Т. И. /Молекулярная генетика, микробиология и вирусология //1988, № 5. С. 27−30.
- Маниатис Т., Фрич Э., Сэмбрук Дж. /Молекулярное клонирование //Москва, «Мир». -1982.
- Патрушев Л.И. /Экспрессия генов //Москва. Наука, 1999. С. 356.
- Пейлиз П., Кингсберри Д.У./ Генетика вирусов гриппа. М.: Медицина, 1986.-С.336
- Ройт А., Бростофф Д., Мейл Д./ Иммунология. //Москва «Мир», 2000.
- Сюрин В. Н., Белоусова Р. В., Фомина Н. В. /Диагностика вирусных болезней животных: Справочник. //М. Агропромиздат. 1991. С. 159 166.
- Фомина Н.В. /Аденовирусная инфекция животных //М.: Колос, 1995.
- Хорвиц М.С. /Аденовирусы и их репликация // «Вирусология» под ред. Филдс, «Мир», 1989.
- Ярилин А.А. Основы иммунологии.// Москва. Медицина, 2000, с. 350 362.
- Abdul-Careem MF, Hunter BD, Sarson AJ, Mayameei A, Zhou H, Sharif S. /Marek's disease virus-induced transient paralysis is associated with cytokine gene expression in the nervous system //Viral Immunol. 2006- 19 (2): 167−76.
- Avakian AP, Poston RM, Kong FK, Van Kampen KR, Tang DC. /Automated mass immunization of poultry: the prospect for nonreplicating human adenovirus-vectored in ovo vaccines //Expert Rev Vaccines. 2007- 6 (3): 457−65
- Akopian T.A., Doronin K.K., Karpov V.A., Naroditsky B.S./ Sequence of the avian adenovirus FAV-1 (CELO) DNA encoding the hexon-associated protein pVI and hexon. Arch.Virol.1996, vl41, p. l 1759−65.
- Amalfitano A, Hauser MA, Ни H, Serra D, Begy CR, Chamberlain JS. Production and characterization of improved adenovirus vectors with the El, E2b, and E3 genes deleted. //J. Virol. 1998 v.- 72, pp. 926−933
- Anderson J., V.J. Yates, et al. The in vitro transformation by an avian adenovirus (CELO). I. Hamster-embryo fibroblastic cultures. J. Natl. Cancer Inst. 1969, v42, pi-7.
- Baigent SJ, Smith LP, Nair VK, Currie RJ. /Vaccinal control of Marek’s disease: current challenges, and future strategies to maximize protection //Vet Immunol Immunopathol. 2006 Jul 15- 112 (l-2):78−86.
- Baohong Cao, John R. Mytinger, Johnny Huard. Adenovirus mediated gene transfer to skeletal muscle.// Microscopy Research and Technique. 2002 Jul 58 (1):45−51
- Barnett BG., Crews CJ., Douglas JT. Targeted adenovirus vectors. // 2002 Bioch. etBioph. Acta V.-1575, pp. 1−14
- Babiuk LA, Tikoo SK. Adenoviruses as vectors for delivering vaccines to mucosal surfaces. // J Biotechnol 2000 v.-83(l-2), pp. 105−13
- Baxi MK, Robertson J, Babiuk LA, Tikoo SK. Mutational analysis of early region 4 of bovine adenovirus type 3. // Virology 2001 v.-290(1), pp.153−63
- Baxi MK, Deregt D, Robertson J, Babiuk LA, Schlapp T, Tikoo SK. Recombinant bovine adenovirus type 3 expressing bovine viral diarrhea virus glycoprotein E2 induces an immune response in cotton rats. // Virology 2000 v.-278(1), pp.234−243
- Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. // Science 1997 v.-275(5304), pp. 1320−1323
- Bergelson JM, Krithivas A, Celi L, Droguett G, Horwitz MS, Wickham T, Crowell RL, Finberg RW. The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses. // J. Virol. 1998 v.- 72(1), pp.415−419
- Berger J, Hauber J, Hauber R, Geiger R, Cullen BR Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells.// Gene. 1988 Jun 15- 66 (1):1−10.
- Benihoud K, Yeh P, Perricaudet M. /Adenovirus vectors for gene delivery. // Curr Opin Biotechnol 1999 v.-10(5), pp.440−447
- Bett A.J., L.A. Prevec, and F.L. Graham. Packaging capacity and stability of the human adenovirus type 5 vector. J.Virol. 1983, v67, p 5911−5921.
- Boyle DB, Selleck P, Heine HG. /Vaccinating chickens against avian influenza with fowlpox recombinants expressing the H7 haemagglutinin //Aust Vet J. 2000- 78(l):44−8.
- Blomer U, Naldini L, Kafri T, Trono D, Verma IM, Gage FH. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. // J Virol 1997 v.-71(9), pp.6641−9
- Bruder JT, Jie T, McVey DL, Kovesdi I. Expression of gpl9K increases the persistence of transgene expression from an adenovirus vector in the mouse lung and liver. // J Virol 1997 v.- 71(10), pp.- 7623−7628
- Buchschacher GL., Jr, Wong-Staal F. Development of lentiviral vectors for gene therapy for human diseases. // Blood 2000 v.-95(8), pp.2499−2504
- Buller RM, Chakrabarti S, Cooper JA, Twardzik DR, Moss B. Deletion of the vaccinia virus growth factor gene reduces virus virulence. // J Virol 1988 v.-62, pp.866−874
- Buscaglia C, Nervi P, Risso M. //Characterization of four very virulent Argentinian strains of Marek’s disease virus and the influence of one of those isolates on synergism between Marek’s disease vaccine viruses //Avian Pathol. 2004- 33 (2): 190−5.
- Cao JX, Krell PJ, Nagy E. Sequence and transcriptional analysis of terminal regions of the fowl adenovirus type 8 genome. // J Gen Virol 1998 v.-79, pp.2507−16
- Caravokuri C., K.N.Leppard. Constitutive episomal expression of a polipeptide pIX in a 293-based cell line complements the defiency of pIX mutant adenovirus type 5. J. Virol. 1995, v69, p 6627−6633.
- Chu G., Hayakawa H., Berg P. Electroporation for the efficient transfection of mammalian cell with DNA. //Nucleic Acids Res 1987 v.-15, pp.1311−1326
- Chen C., Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. // Mol. Cell. Biol 1991 v.- 7, pp.2745−2752
- Chiocca S., Kurtev V., Colombo R., Boggio R., Sciurpi MT., Brosch G., Seiser C., Draetta GF., Cotten M. Hystone Deacetylase 1 inactivation by an adenovirus early gene product. // Curr. Biol 2002 v.-12, pp.594−98
- Chiocca S., Kurzbauer R., Schaffner J., Baker A., Maunter V., Cotten M. The complete DNA sequence and genomic organization of the avian adenovirus CELO. // J Virol 1996 v.- 70, pp.2939−2949
- Chiocca, S., A. Baker, M. Cotten. Identification of a novel antiapoptotic protein, GAM-1, encoded by the CELO adenovirus. // J Virol 1997 v.- 71, pp.3168−3177
- Child SJ, Palumbo GJ, Buller RM, Hruby DE. Insertional inactivation of the large subunit of ribonucleotide reductase encoded by vaccinia virus is associated with reduced virulence in vivo. // Virol 1990 v.-174, pp.625−29
- Chirmule N, Hughes JV, Gao GP, Raper SE, Wilson JM. Role of E4 in eliciting CD4 T-cell and B-cell responses to adenovirus vectors delivered to murine and nonhuman primate lungs. // J Virol 1998 v.- 72(7), pp.6138−6145
- Chen HH, Mack LM, Kelly R, Ontell M, Kochanek S, Clemens PR. Persistence in muscle of an adenoviral vector that lacks all viral genes. // Proc. Natl. Acad. Sci. USA 1997 v.- 94(5), pp.1645−1650
- Cheshenko N, Krougliak N, Eisensmith RC, Krougliak VA. A novel system for the production of fully deleted adenovirus vectors that does not require helper adenovirus. // Gene Ther 2001 v.- 8(11), pp.846−854
- Chillon M., Kremer E.J. Trafficking and propagation of canine adenovirus vectors lacking a known integrin-interacting motif. // Hum Gene Ther 2001 v.-12(14), pp.1815−1823
- Clemens PR, Kochanek S, Sunada Y, Chan S, Chen HH, Campbell KP, Caskey CT. In vivo muscle gene transfer of full-length dystrophin with anadenoviral vector that lacks all viral genes. // Gene Ther 1996 v.- 3(11), pp.965 972
- Cowen B, Calnek BW, Menendez NA, Ball RF. Avian adenoviruses: effect on egg production, shell quality, and feed consumption. // Avian Dis 1978 v.-22(3), pp.459−470
- Cotten M, Wagner E, Zatloukal K, Birnstiel ML. Chicken adenovirus (CELO virus) particles augment receptor-mediated DNA delivery to mammalian cells and yield exceptional levels of stable transformants. // J Virol 1993 v.- 67(7), pp.3777−3785
- Cummins JM., Rosenquist BD. Protection of calves against rhinovirus infection by nasal secretion of interferon induced by infectious bovine rhinotracheitis virus. //Am. J Vet Med 1978 V.-41, pp. 161−165
- Curiel DT, Agarwal S, Wagner E, Cotten M. Adenovirus enhancement of transferrin-polylysine-mediated gene delivery. // Proc Natl Acad Sei USA 1991 v.- 88(19), pp.8850−8854
- Curiel DT. High-efficiency gene transfer employing adenovirus-polylysine-DNA complexes. // Nat Immun 1994 v.-13(2−3), pp.141−164
- Danthinne X., MJ. Imperiale. Production of first generation adenovirus vectors: a review. // Gene Ther 2000 v.-7, pp.1707−1714.
- Douglas JT, Miller CR, Kim M, Dmitriev I, Mikheeva G, Krasnykh V, Curiel DT. A system for the propagation of adenoviral vectors with genetically modified receptor specificities. //Nat Biotechnol 1999 v.-17(5), pp.470−4
- Duisit G., Salvetti A., Moullier P., Cosset F.L. Functional characterization of adenoviral/retroviral chimeric vectors and their use for efficient screening of retroviral producer cell lines. // Hum Gene Ther 1999 v.-10, pp. 189−200
- Evans PS, Benko M, Harrach B, Letchworth GJ. Sequence, transcriptional analysis, and deletion of the bovine adenovirus type 1 E3 region. // Virology 1998 v.-244(l), pp. 173−85
- Feigner PL. Improvements in cationic liposomes for in vivo gene transfer. // Hum Gene Ther 1996 v.-7, pp. 1791−1793
- Feng M., Jackson WH Jr, Goldman CK, Rancourt C, Wang M, Dusing SK, Siegal G, Curiel DT. Stable in vivo transduction via a novel adenoviral/retroviral chimeric vector. // Nat Biotechnol 1997 v.-15, pp.866−870
- Ferrari FK., Samulski T, Shenk T, Samulski RJ. Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. // J Virol 1996 v.-70(5), pp.3227−3234
- Flotte TR., Carter BJ. Adeno-associated virus vectors for gene therapy. // Gene Ther 1995 v.-2, pp.357−362
- Francois A., Eterradossi N., Delmas B., Payet V., Langlois P. Construction of avian adenovirus CELO recombinants in cosmids. // J Virol 2001 v.- 75, pp.5288−5301
- Gall J, Kass-Eisler A, Leinwand L, Falck-Pedersen E. Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes. // J Virol 1996 v.- 70(4), pp.2116−2123
- Gao GP, Yang Y, Wilson JM. Biology of adenovirus vectors with El and E4 deletions for liver-directed gene therapy. // J Virol 1996 v.- 70(12), pp.89 348 943
- Geerligs HJ, Weststrate MW, Pertile TL, Rodenberg J, Kumar M, Chu S. /Efficacy of a combination vaccine containing MDV CVI 988 strain and HVT against challenge with very virulent MDV //Acta Virol. 1999- 43 (2−3): 198 200.
- Gimeno IM, Witter RL, Hunt HD, Reddy SM, Reed WM. /Biocharacteristics shared by highly protective vaccines against Marek’s disease //Avian Pathol. 2004- 33 (l):59−68.
- Graham F.L. Transformation by and oncogenicity of human adenoviruses. // The Adenoviruses. ed.H.S.Ginsberg, 1984
- Graham FL, Smiley J, Russell WC, Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. // J Gen Virol 1977 v.-36(1), pp.59−74
- Graham F.L. and van der Eb A.J. A new technique for the assay of infectivity of human adenovirus 5 DNA.// Virology 1973 v.- 52, pp.456−467
- Graham F.L. and Prevec L. Manipulation of adenovirus vectors. // Methods in Mol. Biol 1994 v.-7, pp.-109−127. (Ed.), The Humana Press Inc., Clifton, NJ.
- Green K.Y., Wold W.S.M. Human adenoviruses: growth, purification and transfection assay. // Methods Enzymology 1980 V.-80, pp.425−431
- Hanahan D. Studies of transformation of Escherichia coli with plasmids. // J Mol Biol 1983 v.166, pp.557−580
- Hess M., Cuzange A., Ruigrok R.W.H., Chroboczek J., Jacrot B. The avian adenovirus penton: two fibres and one base. // J Mol Biol 1995 v.- 252, pp.379 385
- Higgins PC., Phillpotts RJ., Scott GM., Wallace J., Bernhardt LL., Tyrell DA J. Intranasal interferon as protection against experimental respiratory coronavirus infection in volunteers. // Antimicrob. Agents Chemother 1983 v.-24, pp.713−715
- Hillerman M.R., Werner J.H. Recovery of new agents from patientes with acute respiratory illness. // Proc Soc Exp Biol Med 1954 v.- 85, pp. 183−188.
- Hirai K, Sakaguchi M. /Polyvalent recombinant Marek’s disease virus vaccine against poultry diseases //Curr Top Microbiol Immunol. 2001- 255:26 187.
- Hofmann C, Loser P, Cichon G, Arnold W, Both GW, Strauss M. Ovine adenovirus vectors overcome preexisting humoral immunity against human adenoviruses in vivo. // J Virol 1999 v.-73(8), pp.6930−6
- Holland GP, Holland N, Steward MW. Interferon-gamma potentiates antibody affinity in mice with a genetically controlled defect in affinity maturation. // Clin Exp Immunol 1990 v.-82(2), pp.221−6
- Holmes D., Quigley M. A rapid boiling method for the preparation of bacterial plasmids. //Anal Biochem 1981 v.-l 14, p. 193
- Hu H, Serra D, Amalfitano A. Persistence of an E1-, polymerase-. adenovirus vector despite transduction of a neoantigen into immune-competent mice. // Hum Gene Ther 1999 v.- 10(3), pp.355−364
- Huang W., Flint SJ. The tripartite leader sequence of subgroup C adenovirus major late mRNAs can increase the efficiency of mRNA export. // J Virol 1998 v.-72(l), pp.225−235
- Jacobs A, Breakefield XO, Fraefel C. HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis./ZNeoplasia 1999 v.-l, pp.387−401
- Jacobs A, Breakefield XO, Fraefel C. HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part II. Vector systems and applications. // Neoplasia 1999 v.-l, pp.402−416
- Jarosinski KW, Jia W, Sekellick MJ, Marcus PI, Schat KA. /Cellular responses in chickens treated with IFN-alpha orally or inoculated with recombinant Marek’s disease virus expressing IFN-alpha //J Interferon Cytokine Res. 2001- 21 (5):287−96.
- Kawaguchi T, Nomura K, Hirayama Y, Kitagawa T. Establishment and characterization of a chicken hepatocellular carcinoma cell line, LMH. // Cancer Res 1987 v.- 47(16), pp.4460−4464
- Korst RJ., Ailawadi M., Lee JM., Lee S., Yamada R., Mahtabifard A., Crystal RG. Adenovirus gene transfer vectors inhibit growth of lymphatic tumor metastases independent of a therapeutic transgene. // Human Gene Ther 2001 v.-12, pp. 163 9−1649
- Kovesdi I, Brough DE, Bruder JT, Wickham TJ. Adenoviral vectors for gene transfer. // Curr Opin Biotechnol 1997 v.- 8(5), pp.583−589
- Knoblich HV, Sommer SE, Jackwood DJ. /Antibody titers to infectious bursal disease virus in broiler chicks after vaccination at one day of age with infectious bursal disease virus and Marek’s disease virus. Avian Dis. 2000 Oct-Dec- 44 (4):874−84.
- Krasnykh VN, Mikheeva GV, Douglas JT, Curiel DT. Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism. // J Virol 1996 v.- 70(10), pp.6839−6846
- Kremer E.J., Boutin S., Chillon M., Danos O. Canine adenovirus vectors: an alternative for adenovirus-mediated gene transfer. // J Virol 2000 v.- 74(1), pp.505−512
- Kristiansen IS, Halvorsen PA, Gyrd-Hansen D. /Influenza pandemic: perception of risk and individual precautions in a general population / BMC Public Health 2007, 7:48
- Kundig TM, Kalberer CP, Hengartner H, Zinkernagel RM. Vaccination with two different vaccinia recombinant viruses: long-term inhibition of secondary vaccination. // Vaccine 1993 v.-l 1, pp.1154−8
- Labow D, Lee S, Ginsberg RJ, Crystal RG, Korst RJ. Adenovirus vector-mediated gene transfer to regional lymph nodes.//Hum Gene Ther. 2000 Mar 20-ll (5):759−69.
- Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. // Nature 1970 V.-227, pp.680−685
- Laver WG, Younghusband HB, Wrigley NG. Purification and properties of chick embryo lethal orphan virus (an avian adenovirus). // Virology 1971 v.-45(3), pp.598−614
- Laver WG, Younghusband HB, Wrigley NG. Purification and properties of chick embryo lethal orphan virus (an avian adenovirus). // Virology, 1971, v.-45(3), pp.- 598−614.
- Leblois H., Roche C., Di Falco N., Orsini C., Yeh P., Perricaudet M. Stable transduction of actively dividing cells via a novel adenoviral/episomal vector. // Mol Ther 2000 v.-l, pp.314−22
- Lee LE, Witter RL, Reddy SM, Wu P, Yanagida N, Yoshida S. //Protection and synergism by recombinant fowl pox vaccines expressing multiple genes from Marek’s disease virus //Avian Dis. 2003−47(3):549−58.
- Legerski R., Robberson D. Analysis and optimization of recombinant DNA joining reactions.//J of Mol Biol 1985 v.-181, pp.297−312
- Lehrmann H., M. Cotten. Characterization of CELO virus protein that modulate the pRB/E2 °F pathway. J.Virol., 1999, v73, p. 6517−6525.
- Li P., Bellett A.J.D., Parish C.R. The structural proteins of chick embryo lethal orphan virus (fowl adenovirus type 1). // J Gen Virol 1984 v.- 65, pp.1803−1815
- Lichtenberg D. Liposomes: preparation, characterization, and preservation. // Methods Biochem Anal 1988 v.- 33, pp.337−468
- Lieber A, He CY, Polyak SJ, Gretch DR, Barr D, Kay MA. Elimination of hepatitis C virus RNA in infected human hepatocytes by adenovirus-mediated expression of ribozymes. //J Virol 1996 v.- 70(12), pp.8782−8791
- Lieber A, Steinwaerder DS, Carlson CA, Kay MA. Integrating adenovirus-adeno-associated virus hybrid vectors devoid of all viral genes. // J Virol 1999 v.- 73(11), pp.9314−9324
- Lockett LJ, Both GW. Complementation of a defective human adenovirus by an otherwise incompatible ovine adenovirus recombinant carrying a functional El A gene. // Virology 2002 v.-294(2), pp.333−41
- Loser P, Kumin D, Hillgenberg M, Both GW, Hofmann C. Preparation of ovine adenovirus vectors. // Methods Mol Med 2002 v.-69, pp.415−26
- Loser Peter et al. Advances in the development of non-human viral DNA-vectors for gene delivery.// Curr.Gen.Ther, 2001, 2,161−171.
- Markowski-Grimsrud CJ, Schat KA. /Cytotoxic T lymphocyte responses to Marek’s disease herpesvirus-encoded glycoproteins //Vet Immunol Immunopathol. 2002- 90 (3−4): 133−44.
- Mathias P, Wickham T, Moore M, Nemerow G. Multiple adenovirus serotypes use alpha v integrins for infection. // J Virol 1994 v.- 68(10), pp.6811−6814
- Mayr GA, O’Donnell V, Chinsangaram J, Mason PW, Grubman MJ. Immune responses and protection against foot-and-mouth disease virus (FMDV) challenge in swine vaccinated with adenovirus-FMDV constructs. // Vaccine 2001 v.-19(15−16), pp.2152−2162
- Medin JA, Fowler DH. Post-transduction events in retro virus-mediated gene therapy involving hematopoietic stem cells: beyond efficiency issues. // Cell Biochem Suppl 2002 v.-38, pp.46−54
- Merigan TC., Hall TS., Reed SE., Tyrell DAJ. Inhibition of respiratory virus infection by locally applied interferon. // Lancet 1972 v.-l, pp.563−67
- Michiels B, Philips H, Coenen S, Yane F, Steinhauser T, Stuyck S, Denekens J, Van Royen P. /The effect of giving influenza vaccination to general practitioners: a controlled trial NCT00221676. //BMC Med. 2006. 10- 4:17.
- Michael SI, Hong JS, Curiel DT, Engler JA. Addition of a short peptide ligand to the adenovirus fiber protein. // Gene Ther 1995 v.- 2(9), pp.660−8
- Michou A., Lehrmann H., Saltik M., Cotten M. Mutational analysis of the avian adenovirus CELO, which provides a basis for gene delivery vectors. // J Virol 1999 v.- 73, pp.1399−1410
- Mittal SK., L. Prevec, F. Graham, L.A. Babiuk. Development of a bovine adenovirus type 3-based expression vector. // J Gen Virol 1995 v-76, pp.93 102
- Moorhead JW, Clayton GH, Smith RL, Schaack J. A replication-incompetent adenovirus vector with the preterminal protein gene deleted efficiently transduces mouse ears. // J Virol 1999 v.- 73(2), pp.1046−1053
- Morgan DA., Ruscetti FW., Gallo R. Selective in vitro growth of T limphocytes from normal human bone marrows. // Science 1976 v.-193, pp.1007−1008
- Morrison MD, Reid D, Onions D, Spibey N, Nicolson L. Generation of E3-deleted canine adenoviruses expressing canine parvovirus capsid by homologous recombination in bacteria. //Virology 2002 v.-293(l), pp.26−30
- Mosmann T. Rapid Colorimetric Assay for Cellular Growth and Survival: Application to Proliferation and Cytotoxicity Assay. // J of Immunol Methods 1983 v-65, pp.55−63
- S.Nagata, H. Taira, A. Hall, L. Johnsrud, M. Streuli, J. Ecsodi, W. Boll, K. Cantell, C.Weissmann. Sinthesis in E. coli of a polypeptide with human leukocyte interferon activity. // Nature 1980 V.-284, pp. 316−320
- Nair V. /Evolution of Marek’s disease ~ a paradigm for incessant race between the pathogen and the host //Vet J. 2005 Sep- 170 (2): 175−83.
- Nakane PK., Kawaio A.S. Peroxidase-labeled antibody. A new method of conjugation. // J Histochem Cytochem 1974 v.-22, pp. 1084−1091
- Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. // Science 1996 v.-272(5259), pp.263−7
- Nguyen JT., Wu P, Clouse ME, Hlatky L, Terwilliger EF. Adeno-associated virus-mediated delivery of antiangiogenic factors as an antitumor strategy. // Cancer Res 1998 v.-58, pp.5673−5677
- Nygren PA, Stahl S, Uhlen M. Engineering proteins to facilitate bioprocessing. // Trends Biotechnol 1994 v.-12(5), pp. 184−8
- Okuda Y, Ono M, Yazawa S, Shibata I, Sato S. Experimental infection of specific-pathogen-free chickens with serotype-1 fowl adenovirus isolated from a broiler chicken with gizzard erosions. // Avian Dis 2001 v.- 45(1), pp. 19−25
- Olsen JC. Gene transfer vectors derived from equine infectious anemia virus.// GeneTher 1998 v.-5,pp.1481−1487
- Ono M, Okuda Y, Yazawa S, Shibata I, Tanimura N, Kimura K, Haritani M, Mase M, Sato S Epizootic outbreaks of gizzard erosion associated with adenovirus infection in chickens. // Avian Dis 2001 v.- 45(1), pp.268−275
- Paoletti E, Taylor J, Meignier B, Meric C, Tartaglia J. Highly attenuated poxvirus vectors: NYVAC, ALVAC and TROVAC. // Dev Biol Stand 1995 v.-84, pp. 159−63
- Payet, V., C. Arnauld, J. P. Picault, A. Jestin, and P. Langlois. Transcriptional organization of the avian adenovirus CELO. // J Virol 1998 v.-72, pp.9278−9285
- Pickles RJ, McCarty D, Matsui H, Hart PJ, Randell SH, Boucher RC. Limited entry of adenovirus vectors into well-differentiated airway epithelium is responsible for inefficient gene transfer .//J Virol. 1998 Jul-72(7):6014−23.
- Poeschla EM, Wong-Staal F, Looney DJ. Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors. // Nat Med 1998 v.-4(3), pp.354−7
- Qiao C, Yu K, Jiang Y, Li C, Tian G, Wang X, Chen H. /Development of a recombinant fowlpox virus vector-based vaccine of H5N1 subtype avian influenza //Dev Biol (Basel). 2006- 124:127−32.
- Rasmussen UB, Benchaibi M, Meyer V, Schlesinger Y, Schughart K. Novel human gene transfer vectors: evaluation of wild-type and recombinant animal adenoviruses in human-derived cells. // Hum Gene Ther 1999 v.-10(16), pp.2587−99
- Reddy PS, Idamakanti N, Zakhartchouk LN, Babiuk LA, Mehtali M, Tikoo SK. Optimization of bovine coronavirus hemagglutinin-estrase glycoprotein expression in E3 deleted bovine adenovirus-3. // Virus Res 2000 v.-70(l-2), pp.65−73
- Reddy PS, Idamakanti N, Chen Y, Whale T, Babiuk LA, Mehtali M, Tikoo SK. Replication-defective bovine adenovirus type 3 as an expression vector. // J Virol 1999 v.- 73(11), pp.9137−9144
- Reddy PS, Idamakanti N, Hyun BH, Tikoo SK, Babiuk LA. Development of porcine adenovirus-3 as an expression vector. // J Gen Virol 1999 v.- 80(3), pp.563−570
- Reddy PS, Idamakanti N, Babiuk LA, Mehtali M, Tikoo SK. Porcine adenovirus-3 as a helper-dependent expression vector. // J Gen Virol 1999 v.-80(11), pp.2909−2916
- R.N.de Jong, P.C. van der Viet. Mechanism of DNA replication in eucariotic cells: cellular host factors stimulating adenovirus DNA replication. Gene, 236, 1999,1−12.
- Roberts M.L., Athanasopoulos T., Pohlschmidt M., Duisit G., Cosset F.L., Dickson G. Post-mitotic, differentiated myotubes efficiently produce retroviral vector from hybrid adeno-retrovirus templates. // Gene Ther 2001 v.-8, pp.1580−1586
- Roelvink PW, Mi Lee G, Einfeld DA, Kovesdi I, Wickham TJ. Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae. // Science 1999 v.- 286(5444), pp. 1568−71
- Romanczuk H, Galer CE, Zabner J, Barsomian G, Wadsworth SC, O’Riordan CR. Modification of an adenoviral vector with biologically selected peptides: a novel strategy for gene delivery to cells of choice. // Hum Gene Ther 1999 v.- 10(16), pp.2615−2626
- Ross LJ, Binns MM, Tyers P, Pastorek J, Zelnik V, Scott S. /Construction and properties of a turkey herpesvirus recombinant expressing the Marek’s disease virus homologue of glycoprotein B of herpes simplex virus //J Gen Virol. 1993- 74 (Pt3):371−7.
- Roy S, Kobinger GP, Lin J, Figueredo J, Calcedo R, Kobasa D, Wilson JM. /Partial protection against H5N1 influenza in mice with a single dose of a chimpanzee adenovirus vector expressing nucleoprotein //Vaccine. 2007- 25 (39−40): 6845−51.
- Schat KA. /Isolation of Marek’s disease virus: revisited //Avian Pathol. 2005 Apr- 34 (2):91−5.
- Schiaffino MV, Dellambra E, Cortese K, Baschirotto C, Bondanza S, Clementi M, Nucci P, Ballabio A, Tacchetti C, De Luca M. Effective retrovirus-mediated gene transfer in normal and mutant human melanocytes. // Hum Gene Ther 2002 v.-13(8), pp.947−57
- Schwartz JA, Buonocore L, Roberts A, Suguitan A Jr, Kobasa D, Kobinger
- G, Feldmann H, Subbarao K, Rose JK. /Vesicular stomatitis virus vectors expressing avian influenza H5 HA induce cross-neutralizing antibodies and long-term protection//Virology. 2007 15- 366 (1): 166−73.
- Shenk T. Adenoviridae: the viruses and their replication. // Fields virology. / Eds Fields B.N., Knipe D.M., Howley P.M. Fhiladelfhia: 3rd ed. LippincottRaven Publishers, 1996, pp.- 2111−2148
- Sheppard M, Werner W, McCoy RJ, Johnson MA. The major late promoter and bipartite leader sequence of fowl adenovirus. // Arch Virol 1998 v.-143(3), pp.537−48
- Sheppard M, Werner W, Tsatas E, McCoy R, Prowse S, Johnson M. Fowl adenovirus recombinant expressing VP2 of infectious bursal disease virus induces protective immunity against bursal disease. // Arch Virol. 1998 v.-143(5), pp.915−930
- Soifer H., Higo C., Logg CR., Ja-Lu Jih L., Shichinohe T., Harboe-Schmidt E., Mitani K., Kasahara N. A novel, helper-dependent, adenovirus-retrovirus hybrid vector: stable transduction by a two-stage mechanism. // Mol Ther 2002 v.-5, pp.599−608
- Stevenson SC, Rollence M, Marshall-Neff J, McClelland A. Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein. // J Virol 1997 v.- 71(6), pp.4782−4790
- Straus S.E. Adenovirus infection in humans. // The Adenoviruses, ed. by1. H.S.Ginsberg, 1984
- Tan BT., Wu L., Berk AJ. An adenovirus-Epstein Barr virus hibrid vector that stably transforms cultured cells with high efficiency. // J Virol 1999 v.-6, pp.7582−7589
- Tan P.K., Michou A., Bergelson J.M., Cotten M. Defining CAR as a cellular receptor for the avian adenovirus CELO using a genetic analysis of the two viral fibre proteins. // J Gen Virol 2001 v.- 82, pp. 1465−1472
- Tompkins SM, Zhao ZS, Lo CY, Misplon JA, Liu T, Ye Z, Hogan RJ, Wu Z, Benton KA, Tumpey TM, Epstein SL. /Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1 //Emerg Infect Dis. 2007- 13 (3): 426−35.
- Toro H, Tang DC, Suarez DL, Sylte MJ, Pfeiffer J, Van Kampen KR. /Protective avian influenza in ovo vaccination with non-replicating human adenovirus vector//Vaccine. 2007 Apr 12−25(15):2886−91.
- Tuboly T, Nagy E. Sequence analysis and deletion of porcine adenovirus serotype 5 E3 region. // Virus Res 2000 v.-68(2), pp. 109−17
- Tuboly T, Nagy E. Construction and characterization of recombinant porcine adenovirus serotype 5 expressing the transmissible gastroenteritis virus spike gene. // J Gen Virol 2001 v.-82(l), pp.183−90
- Van der Eb A.J., van Kesteren J.W., van Bruggen E.F.J. Structural properties of adenovirus DNAs. // Biochem Biophys Acta 1969 v.-182, pp.- 530−541
- Vile R.G. A marriage of viral vectors. // Nature Biotech 1997 v.-15, pp.840 841
- Wang G, Williams G, Xia H, Hickey M, Shao J, Davidson BL, McCray PB. Apical barriers to airway epithelial cell gene transfer with amphotropic retroviral vectors. // Gene Ther 2002 v.-9(14), pp.922−31
- Wang Q, Greenburg G, Bunch D, Farson D, Finer MH Persistent transgene expression in mouse liver following in vivo gene transfer with a delta El/delta E4 adenovirus vector. // Gene Ther 1997 v.- 4(5), pp.393−400
- Wickham TJ. Targeting adenovirus. // Gene Ther 2000 v.- 7(2), pp. 110−4
- Wickham TJ, Mathias P, Cheresh DA, Nemerow GR. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. // Cell 1993 v.- 73(2), pp.309−319
- Wickham TJ, Segal DM, Roelvink PW, Carrion ME, Lizonova A, Lee GM, Kovesdi I. Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies. // J Virol 1996 v.- 70(10), pp.6831−6838
- W.S.M. Wold, K. Doronin et al. Immune responses to adenoviruses: viral evasion mechanisms and their implications for the clinic. Current opinion in immunology. 1999, vl 1, p.380−386.
- Xu ZZ, Hyatt A, Boyle DB, Both GW. Construction of ovine adenovirus recombinants by gene insertion or deletion of related terminal region sequences. // Virology 1997 v.-230(1), pp.62−71
- Yao Y, Zhao Y, Xu H, Smith LP, Lawrie CH, Sewer A, Zavolan M, Nair V. /Marek's disease virus type 2 (MDV-2)-encoded microRNAs show no sequence conservation with those encoded by MDV-1 // J Virol. 2007- 81 (13):7164−70.
- Yang Y, Nunes FA, Berencsi K, Furth EE, Gonczol E, Wilson JM. /Cellular immunity to viral antigens limits El-deleted adenoviruses for gene therapy. // Proc Natl Acad Sci USA 1994 v.-91, pp.4407−4411.
- Yates V.J., Fry D.E. Observations on a chicken embryo lethal orphan (CELO) virus.//Am J Vet Res 1957 v.-18, pp.657−660.
- Zabner J, Chillon M, Grunst T, Moninger TO, Davidson BL, Gregory R, Armentano D. A chimeric type 2 adenovirus vector with a type 17 fiber enhances gene transfer to human airway epithelia. // J Virol 1999 v.- 73(10), pp.8689−8695.
- Zhang L., Sankar U., Lampe D.J., Robertson H.M., Graham F.L. The Himarl mariner transposase cloned in a recombinant adenovirus vector is functional in mammalian cells. //Nucleic Acids Res 1998 v.-26, pp.3687−3693
- Zhou Y, Tikoo SK. Analysis of early region 1 of porcine adenovirus type 3. // Virology 2001 v.-291(l), pp.68−76.
- Zhou H, Zhao T, Pastore L, Nageh M, Zheng W, Rao XM, Beaudet AL. A Cre-expressing cell line and an El/E2a double-deleted virus for preparation of helper-dependent adenovirus vector. // Mol Ther 2001 v.- 3 (4), pp.613−622.